A Randomized, Double-Blind, Placebo-Controlled Study of Pulsed, Inhaled Nitric Oxide in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis von Nathan, Steven D., Flaherty, Kevin.R., Glassberg, Marilyn.K., Raghu, Ganesh, Swigris, Jeffrey, Alvarez, Roger, Ettinger, Neil, Loyd, Jim, Fernandes, Peter, Gillies, Hunter, Kim, Bo, Shah, Parag, Lancaster, Lisa

Volltext

Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial von Lanzoni, Giacomo, Linetsky, Elina, Correa, Diego, Messinger Cayetano, Shari, Alvarez, Roger A., Kouroupis, Dimitrios, Alvarez Gil, Ana, Poggioli, Raffaella, Ruiz, Phillip, Marttos, Antonio C., Hirani, Khemraj, Bell, Crystal A., Kusack, Halina, Rafkin, Lisa, Baidal, David, Pastewski, Andrew, Gawri, Kunal, Leñero, Clarissa, Mantero, Alejandro M. A., Metalonis, Sarah W., Wang, Xiaojing, Roque, Luis, Masters, Burlett, Kenyon, Norma S., Ginzburg, Enrique, Xu, Xiumin, Tan, Jianming, Caplan, Arnold I., Glassberg, Marilyn K., Alejandro, Rodolfo, Ricordi, Camillo

Volltext

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials von Noble, Paul W, Prof, Albera, Carlo, Prof, Bradford, Williamson Z, MD, Costabel, Ulrich, Prof, Glassberg, Marilyn K, MD, Kardatzke, David, PhD, King, Talmadge E, Prof, Lancaster, Lisa, MD, Sahn, Steven A, Prof, Szwarcberg, Javier, MD, Valeyre, Dominique, Prof, du Bois, Roland M, Prof

Volltext

Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials von Noble, Paul W, Albera, Carlo, Bradford, Williamson Z, Costabel, Ulrich, du Bois, Roland M, Fagan, Elizabeth A, Fishman, Robert S, Glaspole, Ian, Glassberg, Marilyn K, Lancaster, Lisa, Lederer, David J, Leff, Jonathan A, Nathan, Steven D, Pereira, Carlos A, Swigris, Jeffrey J, Valeyre, Dominique, King, Jr, Talmadge E

Volltext

Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities von Glaspole, Ian, Bonella, Francesco, Bargagli, Elena, Glassberg, Marilyn K, Caro, Fabian, Stansen, Wibke, Quaresma, Manuel, Orsatti, Leticia, Bendstrup, Elisabeth

Volltext

Mesenchymal Stem Cells and Idiopathic Pulmonary Fibrosis: Potential for Clinical Testing von TOONKEL, Rebecca L, HARE, Joshua M, MATTHAY, Michael A, GLASSBERG, Marilyn K

Volltext

Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis von Nathan, Steven D, Prof, Albera, Carlo, MD, Bradford, Williamson Z, MD, Costabel, Ulrich, Prof, Glaspole, Ian, MD, Glassberg, Marilyn K, Prof, Kardatzke, David R, PhD, Daigl, Monica, MSc, Kirchgaessler, Klaus-Uwe, MD, Lancaster, Lisa H, MD, Lederer, David J, MD, Pereira, Carlos A, Prof, Swigris, Jeffrey J, MD, Valeyre, Dominique, Prof, Noble, Paul W, MD

Volltext

Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis von Tashiro, Jun, Rubio, Gustavo A, Limper, Andrew H, Williams, Kurt, Elliot, Sharon J, Ninou, Ioanna, Aidinis, Vassilis, Tzouvelekis, Argyrios, Glassberg, Marilyn K

Volltext

Sex and gender in interstitial lung diseases von Kawano-Dourado, Leticia, Glassberg, Marilyn K, Assayag, Deborah, Borie, Raphaël, Johannson, Kerri A

Volltext

Rheumatoid Arthritis-Associated Interstitial Lung Disease: Current Concepts von Brito, Yoel, Glassberg, Marilyn K., Ascherman, Dana P.

Volltext

Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis–Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis von Kass, Daniel J., Nouraie, Mehdi, Glassberg, Marilyn K., Ramreddy, Nitya, Fernandez, Karen, Harlow, Lisa, Zhang, Yingze, Chen, Jean, Kerr, Gail S., Reimold, Andreas M., England, Bryant R., Mikuls, Ted R., Gibson, Kevin F., Dellaripa, Paul F., Rosas, Ivan O., Oddis, Chester V., Ascherman, Dana P.

Volltext

Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis von Costabel, Ulrich, Albera, Carlo, Glassberg, Marilyn K, Lancaster, Lisa H, Wuyts, Wim A, Petzinger, Ute, Gilberg, Frank, Kirchgaessler, Klaus-Uwe, Noble, Paul W

Volltext

Overview of idiopathic pulmonary fibrosis, evidence-based guidelines, and recent developments in the treatment landscape von Glassberg, Marilyn K

Volltext

Arizona Surge Line: An emergent statewide COVID-19 transfer service with equity as an outcome von Villarroel, Lisa, Tams, Erin, Smith, Luke, Rigler, Jessica, Wilson, Dena, Hu, Chengcheng, Glassberg, Marilyn K

Volltext

Urine-derived exosomes from individuals with IPF carry pro-fibrotic cargo von Elliot, Sharon, Catanuto, Paola, Pereira-Simon, Simone, Xia, Xiaomei, Shahzeidi, Shahriar, Roberts, Evan, Ludlow, John, Hamdan, Suzana, Daunert, Sylvia, Parra, Jennifer, Stone, Rivka, Pastar, Irena, Tomic-Canic, Marjana, Glassberg, Marilyn K

Volltext

Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis von Tzouvelekis, Argyrios, Toonkel, Rebecca, Karampitsakos, Theodoros, Medapalli, Kantha, Ninou, Ioanna, Aidinis, Vasilis, Bouros, Demosthenes, Glassberg, Marilyn K

Volltext

Systemic Sclerosis Associated Interstitial Lung Disease: New Directions in Disease Management von Mirsaeidi, Mehdi, Barletta, Pamela, Glassberg, Marilyn K.

Volltext

A Roadmap to Promote Clinical and Translational Research in Rheumatoid Arthritis-Associated Interstitial Lung Disease von Doyle, Tracy J., MD, MPH, Lee, Joyce S., MD, Dellaripa, Paul F., MD, Lederer, James A., PhD, Matteson, Eric L., MD, MPH, Fischer, Aryeh, MD, Ascherman, Dana P., MD, Glassberg, Marilyn K., MD, FCCP, Ryu, Jay H., MD, FCCP, Danoff, Sonye K., MD, PhD, FCCP, Brown, Kevin K., MD, FCCP, Collard, Harold R., MD, FCCP, Rosas, Ivan O., MD, FCCP

Volltext

Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused von Chaudhary, Sachin, Natt, Bhupinder, Bime, Christian, Knox, Kenneth S, Glassberg, Marilyn K

Volltext

Sex and Gender in Lung Disease and Sleep Disorders: A State-of-the-Art Review von Sodhi, Amik, Pisani, Margaret, Glassberg, Marilyn K, Bourjeily, Ghada, D'Ambrosio, Carolyn

Volltext